Equities

Jubilant Pharmova Ltd

JUBLPHARMA:NSI

Jubilant Pharmova Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,111.80
  • Today's Change-27.20 / -2.39%
  • Shares traded227.79k
  • 1 Year change+166.62%
  • Beta1.8833
Data delayed at least 15 minutes, as of Nov 25 2024 09:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue67,02962,81761,302
OPERATING EXPENSES
Cost of revenue total24,22122,22817,870
Selling, general and admin. expenses, total33,18032,19131,071
Depreciation/amortization3,8193,8263,817
Unusual expense(income)1,6892,2820
Other operating expenses, total578560299
Total operating expense63,48761,08753,057
Operating income3,5421,7308,245
Other, net(5)(83)14
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1,7052786,304
Provision for income taxes9789272,174
Net income after taxes727(649)4,130
Minority interest44399.20
Net income before extra. Items771(610)4,139
Total extraordinary items----0
Net income771(610)4,139
Inc.avail. to common excl. extra. Items771(610)4,139
Inc.avail. to common incl. extra. Items771(610)4,139
EPS RECONCILIATION
Basic/primary weighted average shares159159159
Basic/primary eps excl. extra items4.86(3.83)26
Basic/primary eps incl. extra items4.86(3.83)26
Dilution adjustment------
Diluted weighted average shares159159159
Diluted eps excl. extra items4.85(3.83)26
Diluted eps incl. extra items4.85(3.83)26
COMMON STOCK DIVIDENDS
DPS - common stock primary issue5.005.005.00
Gross dividend - common stock796796796
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2,5641,6861,382
SUPPLEMENTAL INCOME
Depreciation, supplemental3,2983,1622,922
Total special items1,6892,30934
NORMALISED INCOME
Normalized income before taxes3,3942,5876,338
Effect of special items on income taxes96980812
Income tax excluding impact of special items1,9471,7352,186
Normalized income after tax1,4478524,152
Normalized income avail. to common1,4918914,161
Basic normalized EPS9.415.6026
Diluted normalized EPS9.395.6026
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.